Skip to main navigation Skip to search Skip to main content

Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART

Helene Mens*, Lasse Fjordside, Jannik Fonager, Jan Gerstoft

*Corresponding author for this work
4 Citations (Scopus)

Abstract

HIV-1 resistance towards integrase inhibitors is a potential threat of the success of HIV-1 combination treatment. G118R is a rare drug resistance mutation conferring pan-integrase resistance. Here, we describe the occurrence of G118R in a HIV-1 subtype-B-positive individual with major compliance problems, detected while the patient was on dolutegravir-based cART. We speculate the pre-selection of M184I/V aided the occurrence of G118R in this case, and discuss the robustness of dolutegravir-based therapies.

Original languageEnglish
JournalInfectious disease reports
Volume14
Issue number4
Pages (from-to)501-504
Number of pages4
ISSN2036-7430
DOIs
Publication statusPublished - 22 Jun 2022

Keywords

  • HIV-1
  • drug resistance
  • integrase inhibitors

Fingerprint

Dive into the research topics of 'Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART'. Together they form a unique fingerprint.

Cite this